Sequana Medical Investor Presentation 2022 - Drug-Resistant Fluid Overload Treatment

Sequana Medical presents its innovative solutions for treating drug-resistant fluid overload, including the alfapump® system and DSR® therapy. The company develops medical devices addressing refractory ascites and other fluid management challenges in patients with advanced disease.